A range of tertiary amines was constructed using a
“traceless” linker on a polystyrene resin (REM resin),
starting from secondary amines, primary amines, and resin-bound
“ammonia”. The methodology is characterized
by three essential steps conducted under ambient conditions: (1)
coupling of the starting amine (Michael addition)
to the resin, (2) activation (quaternization), and (3) cleavage of the
product amine (Hofmann elimination). The
linker is compatible with both acid and base sensitive protecting group
strategies. The nature of the chemistry
ensures that the tertiary amine products are obtained in consistently
high purity (95% or greater). After cleavage of
the product, REM resin is regenerated and can be reused for repeat
syntheses. The yield and purity of repeat batches
is maintained over 5 cycles, allowing the automated synthesis of >0.5
g quantities of pure tertiary amine.
The progesterone receptor is able to bind to a large number and variety of ligands that elicit a broad range of transcriptional responses ranging from full agonism to full antagonism and numerous mixed profiles inbetween. We describe here two new progesterone receptor ligand binding domain x-ray structures bound to compounds from a structurally related but functionally divergent series, which show different binding modes corresponding to their agonistic or antagonistic nature. In addition, we present a third progesterone receptor ligand binding domain dimer bound to an agonist in monomer A and an antagonist in monomer B, which display binding modes in agreement with the earlier observation that agonists and antagonists from this series adopt different binding modes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.